BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    ELECSYS ANTI-TSHR

    MDR report key: 23688786 · Received December 1, 2025

    Report

    Report Number
    1823260-2025-04904
    Event Type
    Malfunction
    Date Received
    December 1, 2025
    Date of Event
    September 30, 2025
    Report Date
    January 8, 2026
    Manufacturer
    ROCHE DIAGNOSTICS
    Product Code
    JZO
    UDI-DI
    07613336160305
    PMA / PMN Number
    K193313
    Removal / Correction Number
    RES 98103
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    CH
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    ISSUES HAVE BEEN IDENTIFIED WITH THE ELECSYS ANTI-TSHR ASSAY, PARTICULARLY AROUND THE 1.75 IU/L MEDICAL DECISION POINT. ROCHE DIAGNOSTICS HAS ISSUED AN URGENT MEDICAL DEVICE CORRECTION FOR THIS ISSUE, ENTITLED "ELECSYS® ANTI-TSHR ASSAY ¿ DEVIATIONS ON COBAS® E 411, 402, AND 801 ANALYZERS." THIS CORRECTION HAS BEEN REPORTED TO FDA. ROCHE DIAGNOSTICS INVESTIGATED AND CONFIRMED THE CUSTOMERS' ALLEGATIONS. THE ROOT CAUSE FOR THE VARIATIONS IN THE ELECSYS ANTI-TSHR ASSAY WAS AN INSUFFICIENCY OF THE ASSAY'S ROUTINE PRODUCTION PROCESS. FOR THE PLATFORM-TO-PLATFORM DEVIATION (COBAS E 411 VS. COBAS E 402/E 801), DIFFERENCES AROSE DUE TO AN INSUFFICIENT ALIGNMENT CONCEPT BETWEEN THE PLATFORMS. THESE VARIATIONS WERE FURTHER INFLUENCED BY UPDATES TO THE ROUTINE PRODUCTION PROCESS FOR THIS ASSAY. FOR THE LOT-TO-LOT DEVIATION ON E 411, MEASURES TAKEN TO ENHANCE ROBUSTNESS LED TO ADDITIONAL SHIFTS. CUSTOMERS WERE ADVISED TO IMMEDIATELY DISCONTINUE USING AND DISCARD THE AFFECTED LOT NUMBERS: 840183 AND 874011 ON THE COBAS E402/E801 ANALYZER. 840177 ON THE COBAS E411 ANALYZER. CUSTOMERS WERE ADVISED TO SWITCH TO THE NEW UNAFFECTED LOT NUMBERS: 908953 ON THE COBAS E402/E801 ANALYZER. 906872 ON THE COBAS E411 ANALYZER. THE COBAS E601 AND E602 MODULES ARE NOT AFFECTED AND CAN BE USED WITH ALL CURRENTLY AVAILABLE LOTS AND WITH THE UPCOMING LOTS WITHOUT RESTRICTIONS.

    Additional Manufacturer Narrative · 0

    THE ANALYZER SERIAL NUMBERS WERE NOT PROVIDED.

    Description of Event or Problem · 0

    THE INITIAL REPORTER STATED THEY RECEIVED QUESTIONABLE HIGH RESULTS FOR AN UNSPECIFIED NUMBER OF PATIENT SAMPLES TESTED WITH ELECSYS ANTI-TSHR ABOVE THE CUT-OFF VALUE OF 1.75 IU/L. THE CUSTOMER COMPLAINED THAT THE VALUES ARE TOO HIGH AS THEY DO NOT MATCH THE CLINICAL STATUS OF THE PATIENTS. THE CUSTOMER PROVIDED SPECIFIC DATA FOR 3 PATIENT SAMPLES. SAMPLE 1 HAD AN INITIAL RESULT OF 1.86 IU/L FROM AN E 411 ANALYZER. THE SAMPLE WAS REPEATED ON AN E 601 ANALYZER AND THE RESULT WAS 1.10 IU/L. SAMPLE 2 HAD AN INITIAL RESULT OF 1.99 IU/L FROM AN E 411 ANALYZER. THE SAMPLE WAS REPEATED ON AN E 601 ANALYZER AND THE RESULT WAS 1.07 IU/L. SAMPLE 3 HAD AN INITIAL RESULT OF 2.11 IU/L FROM AN E 411 ANALYZER. THE SAMPLE WAS REPEATED ON AN E 601 ANALYZER AND THE RESULT WAS 1.06 IU/L.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    40363 ELECSYS ANTI-TSHR THYROID AUTOANTIBODY IMMUNOLOGICAL TEST SYSTEM JZO ROCHE DIAGNOSTICS 84017701 07613336160305

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Unknown